Nonalcoholic Steatohepatitis (NASH) - Current Market and Future Players by Transparecy Market Research

1. Transparency Market Research Nonalcoholic Steatohepatitis (NASH) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023 Single User License: USD 4315.5  Flat 10% Discount!!  Free Customization as per your requirement  You will get Custom Report at Syndicated Report price  Report will be delivered with in 15-20 working days Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com Request Sample Buy Now

2. REPORT DESCRIPTION Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Nonalcoholic Steatohepatitis (NASH) Market ".This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. Nonalcoholic Steatohepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD), characterized by hepatocyte injury (ballooning) marked by presence of hepatic steatosis, inflammation, and fibrosis. Clinical studies have identified a strong correlation of NASH with certain risk factors such as insulin resistance, oxidative stress and release of toxic inflammatory proteins (cytokines). Moreover, recent breakthroughs have taken place in mapping the genetic factors behind NASH to identify the predisposition of an individual or population at large for developing NASH. The disease requires liver transplantation surgeries in the event of the organ failing. However, at present, the information on natural history of this disease is sparse. Browse Full Report with TOC: http://www.transparencymarketresearch.com/nonalcoholic-steatohepatitis-market.html The American Liver Foundation has raised issues concerning the propensity of NASH progression. Since, NASH patients whose condition has progressed to cirrhosis are at a higher risk of developing hepatocellular cancer (HCC). Thus, NASH progression into advanced liver disease has become a primary concern, as NASH is being identified as one of the potential causes for hepatocellular cancer (HCC), according to the facts and findings published by American Liver Foundation. In terms of diagnostic technology for NASH, NASH can be first identified by elevations in liver functioning tests based on the blood sample, without the presence of signs and symptoms of other liver disorders among those who are usually nonalcoholic or rarely consume alcohol. However, liver biopsy is a widely accepted confirmatory diagnostic test for distinguishing NASH from other liver morbidities. Therefore, there is a need to develop new diagnostic and therapeutic strategies in the NASH market. For instance, OWLiver test is an in vitro patented diagnostic test technology for determination of the stage of non-alcoholic fatty liver disease and differentiates simple steatosis and non-alcoholic steatohepatitis (NASH). It is a metabolomic based non-invasive assays for fatty liver screening and for NASH diagnosis, which is developed and patented by One Way Liver Genomics, S.L. (OWL). Hence, there is a potential untapped

3. market for diagnosis of NASH through non-invasive diagnostic technology, which would aid identification of NASH in early stages and for screening at risk population who are at greater risk of developing NASH. Therefore, the market for Nonalcoholic Steatohepatitis (NASH) is currently at a nascent stage as there are no U.S. FDA approved drugs for NASH to date. However, there are a number of pipeline drugs in Phase III and II such as Elafibranor, Aramchol etc., which are potential drug candidates for entering the NASH market. There is a huge potential for biotech and pharmaceutical companies for channeling their research and development activities for interventions in diagnosis and treatment of NASH. The key drivers, which will fuel this market, are attributed to the increasing incidence of NAFLD cases, which may eventually transform to NASH, obesity, changing lifestyle patterns, which have a close association with NASH. The overall growth in the market can be linked with the association of NASH with other morbid conditions such as obesity and insulin resistance. Therefore, there is a huge unmet demand for NASH drugs and other therapeutic treatment for this disease, which offers lucrative opportunities for the market players. Players in the market for NASH include AstraZeneca plc, Echosense SA, Exalenz Bioscience Inc., Galmed Pharmaceuticals Ltd., Galectin Therapeutics Inc., GENFIT Corp, Intercept Pharmaceuticals, Inc., One Way Liver Genomics, S.L, Matinas Biopharma Holdings, Inc. Perspectum Diagnostics, and Vital Therapies, Inc. Read More Reports on Healthcare IT Market: http://www.transparencymarketresearch.com/healthcareit-market-reports-19.html This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of Market growth drivers Factors limiting market growth Current market trends Market structure Market projections for upcoming years This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of

4. top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. Reasons for Buying this Report This report provides pin-point analysis for changing competitive dynamics It provides a forward looking perspective on different factors driving or restraining market growth It provides a six-year forecast assessed on the basis of how the market is predicted to grow It helps in understanding the key product segments and their future It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments It provides distinctive graphics and exemplified SWOT analysis of major market segments Enquiry before Buying @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7691 About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

5. Contact us: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/